biosimilars market

Global Biosimilars Market Analysis 2016-2020 and Forecast 2021-2026

  • Published Date: 2021-02-18
  • Report ID: 56627
  • Pages: 80
  • Format: prudent report format

Snapshot

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company.
The global Biosimilars market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Biosimilars by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Injection
Tablets
Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Sandoz International
Hospira
Teva Pharmaceutical
Dr. Reddys Laboratories
Biocon
Mylan
Amgen
Celltrion
Roche Diagnostics
Merck KGaA

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)


Table of Contents
1 Industry Overview
1.1 Biosimilars Industry
Figure Biosimilars Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Biosimilars
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Biosimilars
1.2.2 Downstream
Table Application Segment of Biosimilars
Table Global Biosimilars Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Biosimilars Market by Type
3.1 By Type
3.1.1 Injection
Table Major Company List of Injection
3.1.2 Tablets
Table Major Company List of Tablets
3.1.3 Others
Table Major Company List of Others
3.2 Market Size
Table Global Biosimilars Market 2016-2020, by Type, in USD Million
Figure Global Biosimilars Market Growth 2016-2020, by Type, in USD Million
Table Global Biosimilars Market 2016-2020, by Type, in Volume
Figure Global Biosimilars Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Biosimilars Market Forecast 2021-2026, by Type, in USD Million
Table Global Biosimilars Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Sandoz International (Company Profile, Sales Data etc.)
4.1.1 Sandoz International Profile
Table Sandoz International Overview List
4.1.2 Sandoz International Products & Services
4.1.3 Sandoz International Business Operation Conditions
Table Business Operation of Sandoz International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Hospira (Company Profile, Sales Data etc.)
4.2.1 Hospira Profile
Table Hospira Overview List
4.2.2 Hospira Products & Services
4.2.3 Hospira Business Operation Conditions
Table Business Operation of Hospira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Teva Pharmaceutical (Company Profile, Sales Data etc.)
4.3.1 Teva Pharmaceutical Profile
Table Teva Pharmaceutical Overview List
4.3.2 Teva Pharmaceutical Products & Services
4.3.3 Teva Pharmaceutical Business Operation Conditions
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Dr. Reddys Laboratories (Company Profile, Sales Data etc.)
4.4.1 Dr. Reddys Laboratories Profile
Table Dr. Reddys Laboratories Overview List
4.4.2 Dr. Reddys Laboratories Products & Services
4.4.3 Dr. Reddys Laboratories Business Operation Conditions
Table Business Operation of Dr. Reddys Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Biocon (Company Profile, Sales Data etc.)
4.5.1 Biocon Profile
Table Biocon Overview List
4.5.2 Biocon Products & Services
4.5.3 Biocon Business Operation Conditions
Table Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Mylan (Company Profile, Sales Data etc.)
4.6.1 Mylan Profile
Table Mylan Overview List
4.6.2 Mylan Products & Services
4.6.3 Mylan Business Operation Conditions
Table Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Amgen (Company Profile, Sales Data etc.)
4.7.1 Amgen Profile
Table Amgen Overview List
4.7.2 Amgen Products & Services
4.7.3 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Celltrion (Company Profile, Sales Data etc.)
4.8.1 Celltrion Profile
Table Celltrion Overview List
4.8.2 Celltrion Products & Services
4.8.3 Celltrion Business Operation Conditions
Table Business Operation of Celltrion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Roche Diagnostics (Company Profile, Sales Data etc.)
4.9.1 Roche Diagnostics Profile
Table Roche Diagnostics Overview List
4.9.2 Roche Diagnostics Products & Services
4.9.3 Roche Diagnostics Business Operation Conditions
Table Business Operation of Roche Diagnostics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Merck KGaA (Company Profile, Sales Data etc.)
4.10.1 Merck KGaA Profile
Table Merck KGaA Overview List
4.10.2 Merck KGaA Products & Services
4.10.3 Merck KGaA Business Operation Conditions
Table Business Operation of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Biosimilars Sales Revenue 2016-2020, by Company, in USD Million
Table Global Biosimilars Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Biosimilars Sales Revenue Share in 2020, by Company, in USD Million
Table Global Biosimilars Sales Volume 2016-2020, by Company, in Volume
Table Global Biosimilars Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Biosimilars Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Biosimilars Market Concentration, in 2020
Figure Europe Biosimilars Market Market Concentration, in 2020
Figure Asia-Pacific Biosimilars MMarket Concentration, in 2020
Figure South America Biosimilars Market Concentration, in 2020
Figure Middle East & Africa Biosimilars Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Ankylosing Spondylitis
Figure Biosimilars Demand in Ankylosing Spondylitis, 2016-2020, in USD Million
Figure Biosimilars Demand in Ankylosing Spondylitis, 2016-2020, in Volume
6.1.2 Demand in Tumor
Figure Biosimilars Demand in Tumor, 2016-2020, in USD Million
Figure Biosimilars Demand in Tumor, 2016-2020, in Volume
6.1.3 Demand in Rheumatoid Arthrtis
Figure Biosimilars Demand in Rheumatoid Arthrtis, 2016-2020, in USD Million
Figure Biosimilars Demand in Rheumatoid Arthrtis, 2016-2020, in Volume
6.1.4 Demand in Cardiovascular
Figure Biosimilars Demand in Cardiovascular, 2016-2020, in USD Million
Figure Biosimilars Demand in Cardiovascular, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Biosimilars Demand Forecast 2021-2026, by Application, in USD Million
Figure Biosimilars Market Growth 2021-2026, by Application, in USD Million
Figure Biosimilars Market Share in 2026, by Application, in USD Million
Table Biosimilars Demand Forecast 2021-2026, by Application, in Volume
Table Biosimilars Market Growth 2021-2026, by Application, in Volume
Table Biosimilars Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Biosimilars Production 2016-2020, by Region, in USD Million
Table Biosimilars Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Biosimilars Market 2016-2020, by Region, in USD Million
Table Global Biosimilars Market Share 2016-2020, by Region, in USD Million
Table Global Biosimilars Market 2016-2020, by Region, in Volume
Table Global Biosimilars Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure North America Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Biosimilars Market Size 2016-2020, by Country, in USD Million
Table North America Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure Europe Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Biosimilars Market Size 2016-2020, by Country, in USD Million
Table Europe Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Biosimilars Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure South America Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Biosimilars Market Size 2016-2020, by Country, in USD Million
Table South America Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Biosimilars Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Biosimilars Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Biosimilars Market Forecast 2021-2026, by Region, in USD Million
Table Biosimilars Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.